Cited by 1413D Printing in Biomedical ResearchMicrofluidic and Capillary Electrophoresis ApplicationsTissue Engineering and Regenerative Medicine

Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering

Open access
Osaki, Tatsuya, Sivathanu, Vivek, Kamm, Roger D·2018·Current Opinion in Biotechnology

Abstract

Vascularization of micro-tissues in vitro has enabled formation of tissues larger than those limited by diffusion with appropriate nutrient/gas exchange as well as waste elimination. Furthermore, angiocrine signaling from the vasculature may be essential in mimicking organ-level functions in these micro-tissues. In drug screening applications, the presence of an appropriate blood-organ barrier in the form of a vasculature and its supporting cells (pericytes, appropriate stromal cells) may be essential to reproducing organ-scale drug delivery pharmacokinetics. Cutting-edge techniques including 3D bioprinting and in vitro angiogenesis and vasculogenesis could be applied to vascularize a range of tissues and organoids. Herein, we describe the latest developments in vascularization and prevascularization of micro-tissues and provide an outlook on potential future strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.copbio.2018.03.011

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The recapitulation of more realistic vascularization demands the use of more sophisticated microfabrication techniques.

    “The recapitulation of more realistic vascularization demands the use of more sophisticated microfabrication techniques [181].”

    From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [181]

    The In vitro vascularization section describes 3D printing and microfluidic approaches for creating vascular networks, while noting that current 3D printing cannot produce the smallest capillaries. The Future outlook says advances in bioprinting and biomaterials are likely to improve reproduction of complex in vivo tissues. It does not say that more realistic vascularization demands more sophisticated microfabrication techniques specifically; it also describes angiogenesis and vasculogenesis as routes to fine capillary structures. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Osaki, T., Sivathanu, V., & Kamm, R. D.
Affiliations
  • Massachusetts Institute of Technology (US)
  • Singapore-MIT Alliance for Research and Technology (SG)
Corresponding author
Kamm, Roger D
Venue
Current Opinion in Biotechnology
Publisher
Elsevier BV
Published
2018-08
Volume
52
Pages
116-123
ISSN
0958-1669 (ISSN-L)
OpenAlex
W2797015192
Cited by
141
References
64
Citations by year
2026: 11 · 2025: 20 · 2024: 17 · 2023: 18 · 2022: 24 · 2021: 16 · 2020: 16 · 2019: 16 · 2018: 3
FWCI
1.04
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Biotechnology (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation (CBET-0939511)
  • JSPS (Japan Society for the Promotion of Science)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
organ-on-a-chip, vascularization, microfluidics, drug screening, disease models, tissue engineering, angiogenesis, vasculogenesis, 3D bioprinting, organoids, pericytes, angiocrine signaling, pharmacokinetics, prevascularization
MeSH terms
Drug Evaluation, Preclinical, Humans, Organ Specificity, Neovascularization, Physiologic, Tissue Engineering, Microfluidics, Bioprinting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review